- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
6
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
6 companies
Abbott India
Market Cap: ₹571.1b
Operates as a pharmaceutical company in India.
500488
₹26,877.00
7D
-3.4%
1Y
-11.7%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹374.2b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,208.70
7D
-4.4%
1Y
-33.0%
Rubicon Research
Market Cap: ₹165.7b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹1,005.60
7D
5.9%
1Y
n/a
Sanofi India
Market Cap: ₹71.6b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,106.85
7D
-1.8%
1Y
-50.0%
Curis Lifesciences
Market Cap: ₹954.0m
Operates as a pharmaceutical manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as tablets, capsules, external preparations, oral liquid, and sterile ophthalmic ointments in India.
CURIS
₹118.00
7D
-4.8%
1Y
n/a
Welcure Drugs and Pharmaceuticals
Market Cap: ₹358.4m
Engages in trading of medical products in India.
524661
₹0.29
7D
0%
1Y
-72.3%